Morgellons and Lyme disease are often discussed together, but Morgellons does not automatically mean Lyme disease. Some patients may have Lyme disease, tick exposure, relapsing fever Borrelia, Bartonella, or other infections that deserve careful evaluation. But a Lyme-only explanation can also create a dangerous blind spot when syphilis, rash patterns, testing limitations, geography, congenital history, or false-positive Lyme testing are ignored.
This article is not anti-Lyme. It is pro-patient. Morgellons patients deserve to be believed, examined, and protected from oversimplified explanations. Lyme disease may matter for some patients, but it should not become the only diagnosis anyone is allowed to discuss.
That is especially true when the patient has a macular, papular, or maculopapular-appearing rash, neurologic symptoms, skin lesions, eye or ear symptoms, pregnancy or congenital concerns, confusing test results, or a positive Lyme screen that may not tell the whole story.
Patient takeaway: A positive Lyme story should not automatically end the investigation. Morgellons patients deserve a full differential diagnosis.
The Core Problem: One Rash Can Have Many Causes
Morgellons disease is best known for skin lesions and fibers or filaments that may be embedded in, under, or projecting from the skin. Patients may also report burning, stinging, crawling sensations, fatigue, cognitive symptoms, joint pain, and other systemic complaints.
But rashes and skin findings are not always specific. A macular rash, a papular rash, and a maculopapular rash are not identical descriptions. A rash may point toward many possibilities, including viral illness, drug reaction, autoimmune disease, tick-borne infection, secondary syphilis, or another dermatologic condition.
That is why rash morphology matters. Patients should not be told, “It is just Morgellons,” “It is just Lyme,” or “It is just anxiety” without a careful exam and a serious differential diagnosis.
Quick Comparison: Lyme, Relapsing Fever Borrelia, and Syphilis
| Condition | Why It Matters for Morgellons Patients |
|---|---|
| Lyme disease | Can cause rash, neurologic symptoms, fatigue, joint pain, and systemic illness. Some Morgellons literature has proposed an association with Borrelia. |
| Relapsing fever Borrelia | Can complicate Lyme testing and interpretation. A Borrelia-positive result does not always mean classic Lyme disease. |
| Syphilis | A spirochetal infection that can mimic other diseases, cause rashes, involve the nervous system, affect pregnancy, and cross-react with Lyme testing. |
| Borrelia mayonii | A Lyme-causing Borrelia species associated with atypical Lyme-like rashes, including patchy or confluent macular erythema in reported cases. |
Why Morgellons and Syphilis Belong in the Same Conversation
Syphilis is caused by Treponema pallidum, a spirochete. Lyme disease is most often caused by Borrelia burgdorferi, another spirochete. They are not the same disease, but the comparison matters because syphilis is the older and better-documented spirochetal illness.
Syphilis teaches medicine that spirochetal infections can move through stages, affect the skin, involve the nervous system, mimic other diseases, complicate testing, become latent, and cause serious late consequences when missed.
The question is not “Is every Morgellons case syphilis?” The better question is: “Has syphilis been seriously ruled out when the clinical picture makes it relevant?”
Syphilis Is Not Rare History — It Is Resurging
Many patients are shocked to learn that syphilis has been resurging for years. The word still carries an old-fashioned stigma, so people assume it is rare, obvious, or limited to someone else’s risk category. That assumption can be dangerous.
Public health agencies have documented a long resurgence of syphilis in the United States. Congenital syphilis, which occurs when syphilis is passed from mother to baby during pregnancy, has become especially alarming.
This matters for Morgellons patients because syphilis can involve the skin, nervous system, eyes, hearing, pregnancy, and cardiovascular system. It can produce macular, papular, or maculopapular rashes. It can become latent. It can be congenital. It can also be missed when clinicians or patients assume it is too unlikely to consider.
South Carolina and Georgia Show This Is a Regional Patient-Safety Issue
Syphilis is not just a national statistic. It is a serious regional issue in the Southeast. South Carolina and Georgia have both reported major congenital syphilis concerns in recent years, showing that this is not an outdated diagnosis from old medical textbooks.
Congenital syphilis is preventable, but it can cause miscarriage, stillbirth, infant death, premature birth, low birth weight, and long-term disability when missed. When a preventable spirochetal disease is still causing serious outcomes in modern medicine, it deserves attention.
Patient takeaway: If you live in the Southeast and have unexplained rash, neurologic symptoms, pregnancy history, congenital concerns, or confusing Lyme testing, syphilis should not be dismissed as “too rare.”
Australia Shows the Problem With a Lyme-Only Lens
Australia is an important Southern Hemisphere comparison. Medical literature has stated that locally acquired classic Lyme disease has not been convincingly identified in Australia. Lyme disease can be acquired overseas and later diagnosed in Australia, but that is different from locally acquired classic Lyme disease.
At the same time, Australia has faced a serious syphilis resurgence, including national public-health concern over infectious and congenital syphilis.
That contrast matters. If a patient in Australia has a Lyme-like or Morgellons-like illness, a Lyme-only explanation may not fit the strongest available evidence. But syphilis is clearly present, increasing, and serious enough to require coordinated public-health action.
The patient-safety lesson is broader than Australia: diagnosis should follow evidence, geography, exposure history, symptoms, and testing limitations — not community pressure to force every complex illness into one tick-borne narrative.
Syphilis Is Infectious Enough to Move Through Families
Another reason syphilis is underestimated is that many people think of it only as a sexually transmitted infection in obvious adult-risk situations. Sexual transmission is the main route, and congenital transmission from mother to baby is a major public-health concern. But published case reports also show that syphilis can sometimes spread through close-contact family scenarios when infectious lesions, saliva, blood, mucous patches, or contaminated personal items are involved.
One striking report described acquired syphilis moving through three generations of a Chinese family. The grandfather reportedly acquired syphilis through unprotected commercial sex and transmitted it to his wife sexually. The son appeared to acquire infection after sharing the grandfather’s manual razor and cutting his jaw. The grandmother, who was the child’s primary caregiver, had a habit of pre-chewing food before feeding the child. After sexual abuse was ruled out, the child’s syphilis was attributed mainly to the grandmother’s pre-chewing during an infectious stage.
That case is not included to create fear or shame. It is included because it shows why stereotypes are dangerous. Families may deny syphilis risk because they are thinking only about one route of exposure, while the infection may be moving through pregnancy, close contact, oral lesions, contaminated razors, or caregiving practices.
Morgellons Is Associated With Skin Lesions and Some Rash Patterns
Morgellons disease is most consistently described by skin lesions and fibers or filaments. However, rash patterns also matter. Morgellons staging literature has described macular rashes and small papular lesions, and patients may describe or photograph skin findings that appear macular, papular, or maculopapular.
This does not mean every maculopapular rash is Morgellons. It means rash morphology should be documented carefully and interpreted in context. A macular, papular, or maculopapular-appearing rash can also occur with secondary syphilis, viral illness, drug reactions, autoimmune conditions, tick-borne infections, and other causes.
Patients should photograph rashes under consistent lighting, note whether palms or soles are involved, watch for mucous membrane findings, and seek evaluation when symptoms are spreading, systemic, painful, neurologic, or unexplained.
Syphilis Can Trigger False-Positive Lyme Tests
One of the most important patient-safety points is that syphilis can cross-react with Lyme disease testing. CDC notes that false-positive Lyme serology can occur in patients with other conditions, including syphilis, relapsing fever, rheumatoid arthritis, and Epstein-Barr virus infection.
That means a positive Lyme screen does not automatically prove that Lyme disease explains the patient’s illness. Testing must be interpreted with symptoms, geography, exposure history, pretest probability, confirmatory testing, and competing diagnoses in mind.
This is especially important for Morgellons patients because a positive Lyme result can quickly become the center of the story. Once that happens, other explanations may be ignored. But if syphilis can help create a false-positive Lyme result, then syphilis should not be dismissed after a Lyme test becomes positive.
The Opposite Does Not Appear to Be True
The relationship does not appear to work equally in both directions. A study on cross-reactivity between Lyme and syphilis screening assays supported the known problem of Lyme screening cross-reactivity among syphilis-positive sera. But it reported evidence against the possibility that previous Borrelia burgdorferi infection causes false-positive syphilis screening tests.
That asymmetry matters. If syphilis can make Lyme testing look positive, but Lyme disease does not appear to cause false-positive syphilis screens in the same way, then syphilis testing has a special role in the differential diagnosis.
Patient takeaway: A Lyme-positive story should not automatically end the investigation when rash, neurologic symptoms, congenital concerns, or exposure history still make syphilis relevant.
Relapsing Fever Borrelia Can Also Complicate the Lyme Story
There is another layer patients should understand: not every Borrelia-positive result means classic Lyme disease. Lyme disease is usually associated with the Borrelia burgdorferi group. But there are also relapsing fever Borrelia species, including hard-tick relapsing fever organisms such as Borrelia miyamotoi and soft-tick relapsing fever organisms such as Borrelia hermsii, Borrelia turicatae, and others.
This matters because relapsing fever Borrelia can overlap clinically and serologically with Lyme disease. CDC warns that patients with relapsing fevers may have false-positive Lyme serology, and that some tests can cross-react with other Borrelia species.
For Morgellons patients, this is another reason not to stop at a simple label. A positive test for relapsing fever Borrelia should be taken seriously, but it should also be interpreted carefully. Which Borrelia species or group was tested? Was the test PCR, IgM, IgG, immunoblot, or another method? Was the sample collected during an acute febrile episode? Does the clinical history actually fit?
This does not make the result meaningless. It makes it more specific. A relapsing fever Borrelia result may be clinically important, but it is not the same as saying every symptom is classic Lyme disease, and it does not remove syphilis from the differential diagnosis when the rash pattern, neurologic symptoms, or testing history make syphilis relevant.
A Real-World Example: Borrelia Mayonii and Confluent Macular Rash
Borrelia mayonii is a real Lyme-causing Borrelia species. CDC has reported detection of B. mayonii outside its original Upper Midwest setting, including a New York case confirmed by PCR. That matters because tick-borne disease geography can change.
But this also creates a diagnostic danger. Because B. mayonii has been associated with atypical, more diffuse Lyme-like rashes, some clinicians or online Lyme discussions may be tempted to treat an unusual rash as a Lyme answer too quickly.
In one reported Borrelia mayonii case, the rash was described as patchy or confluent macular erythema on the torso. That is not the same thing as saying the patient had a classic bullseye rash, and it is also not the same thing as saying the rash was specifically maculopapular.
This distinction matters because rash morphology is part of the differential diagnosis. A macular rash, a papular rash, and a maculopapular rash are not identical descriptions. Secondary syphilis can produce macular, papular, or maculopapular lesions, while Borrelia mayonii may produce more diffuse or atypical Lyme-like rashes. Patients deserve careful description, not diagnostic shortcuts.
This is not anti-Lyme. It is pro-patient. Borrelia mayonii may be relevant in some cases. But an atypical rash plus a Lyme narrative should not erase syphilis, relapsing fever Borrelia, drug reactions, viral illness, or other causes from the differential.
A Positive Lyme Test Should Not End the Investigation
Lyme disease is real. Tick-borne infections are real. Some Morgellons patients may have Lyme disease, Borrelia exposure, Bartonella, relapsing fever Borrelia, or other infections that deserve evaluation. But no serious diagnostic process should stop at the first explanation that feels emotionally satisfying.
A positive Lyme test can mislead when it is treated as the final answer instead of one piece of evidence. That is especially true when patients are tested through nonstandard pathways, when only selected bands are emphasized, when exposure history is unclear, or when a different spirochetal infection could be cross-reacting.
Patients deserve to ask: Which Lyme test was used? Was it CDC-recommended two-tier testing? Was it a screening test only? Could cross-reactivity be involved? Was syphilis ruled out with both treponemal and nontreponemal testing? Were titers followed? Were neurologic, ocular, otic, congenital, or late-stage concerns evaluated?
There May Not Be Enough Tick-Bite Evidence for Every Lyme Narrative
Patients also deserve a reality check about tick-bite narratives. Lyme disease is common enough to be a major public-health issue, and many people are bitten by ticks each year. But that does not mean every unexplained rash, every neurologic symptom, every fiber case, every chronic illness, or every Morgellons-like presentation should automatically be labeled tick-acquired Lyme disease.
The stronger point is not that Lyme disease is impossible. The stronger point is that the evidence must match the claim. Geography, exposure history, local tick ecology, test quality, confirmatory testing, clinical findings, and competing diagnoses all matter.
When the evidence for tick-acquired Lyme is weak, but the evidence for a syphilis differential is strong, patients should not be pressured into a Lyme-only explanation. They deserve a clinician who can think beyond community narratives.
Syphilis Testing Can Be Complicated in Congenital and Late-Stage Disease
Syphilis testing is useful, but it is not perfect. A patient may be told syphilis has been “ruled out” when the testing was incomplete, performed at the wrong stage, interpreted without clinical context, or never followed properly.
CDC guidance emphasizes that a presumptive diagnosis of syphilis generally requires both a nontreponemal test, such as RPR or VDRL, and a treponemal test, such as TP-PA, EIA, CIA, or another treponemal assay. Using only one type of test can create false-negative or false-positive problems.
Congenital cases create additional problems. Infant testing can be difficult because maternal antibodies can cross the placenta and confuse interpretation. Neonatal treponemal testing is not recommended for diagnosis because passively transferred maternal antibody can persist.
Late-stage disease has its own limitations. CDC laboratory recommendations note that nontreponemal test sensitivity decreases during longer-duration latent syphilis. Reported sensitivity is lower in some late latent and tertiary scenarios than many patients would expect.
For Morgellons patients, this means a vague statement like “my syphilis test was negative once” may not be enough. The better questions are: Which tests were done? At what stage? Were both test types used? Were titers followed? Was congenital or late-stage disease considered? Were neurologic, ocular, otic, or cardiovascular symptoms evaluated?
Even PCR Testing Is Not a Final Verdict
Patients often hear the word “PCR” and assume it is final. If PCR is positive, it can be powerful evidence. But a negative PCR does not always mean an organism was never involved. PCR depends on the right specimen, the right site, the right stage of disease, the right target, adequate organism burden, and proper tissue handling.
This is especially important for syphilis. CDC laboratory recommendations state that no FDA-cleared NAATs are available for syphilis in the United States, although some laboratories use validated laboratory-developed molecular tests. Sensitivity varies by disease stage and specimen type.
A striking example comes from a reported case of a 43-year-old woman who died suddenly from a ruptured thoracic aortic aneurysm. Her aorta had the classic “tree-bark” appearance associated with syphilitic aortitis. Histology showed plasma-cell inflammation, and immunohistochemistry identified multiple spirochete-like organisms consistent with Treponema pallidum. Yet postmortem syphilis serology was negative, and PCR testing on formalin-fixed aortic tissue was also negative.
That case does not mean PCR is useless. It means PCR is a tool, not a verdict. A negative PCR from one specimen does not automatically settle a complex spirochetal question.
Negative Syphilis PCR in Morgellons Specimens Should Not Be Overinterpreted
This matters for Morgellons research. If a limited set of Morgellons specimens is tested by PCR for Treponema pallidum and nothing is found, that result should be reported honestly. But it should not be stretched into a universal claim that syphilis can never be associated with Morgellons-like illness.
Syphilis itself teaches this lesson. Treponema pallidum can be difficult to detect directly in tissue, especially outside the most infectious early lesions. Negative molecular testing from limited tissue cannot erase a diagnosis when the broader clinical, histologic, serologic, or epidemiologic picture still supports it.
For Morgellons patients, the cautious conclusion is best: negative syphilis PCR in some Morgellons specimens is not proof of no relationship. It is one data point. The clinical picture still matters.
Even Standard Syphilis Treatment Requires Follow-Up
Another misconception is that syphilis treatment is always simple: one shot, one answer, case closed. Early syphilis is often highly treatable, and penicillin remains the standard therapy. But follow-up still matters.
CDC notes that some people with primary or secondary syphilis treated with recommended therapy do not achieve the expected fourfold decline in nontreponemal titers within 12 months. That does not automatically prove ongoing infection in every case, but it does mean follow-up can be complicated.
Persistent or recurrent symptoms, rising titers, neurologic findings, uncertain follow-up, reinfection risk, or possible central nervous system involvement all change the conversation. Patients should not be satisfied with vague reassurance if symptoms and testing history do not match.
Syphilis Can Be Fatal When Missed
Patients also need to understand that syphilis is not only a rash. Untreated or missed syphilis can become neurologic, ocular, otic, congenital, cardiovascular, and fatal. Cardiovascular syphilis is now considered uncommon in the antibiotic era, but modern case reports still show that it can happen.
The 43-year-old woman with a ruptured thoracic aortic aneurysm is one example of why this matters. Her case showed features strongly suggestive of syphilitic aortitis despite negative serology and negative PCR from formalin-fixed tissue. Other cases of syphilitic aneurysm and aortitis continue to appear in the literature.
The patient-facing message is not panic. It is seriousness. Syphilis can be silent, deceptive, and dangerous when it is missed.
Dr. Alan MacDonald’s Syphilis Comparison Should Not Be Forbidden
Dr. Alan MacDonald, a pathologist known for his work on Borrelia and tissue-based investigation, drew a provocative comparison between Lyme disease and syphilis. He reportedly suggested that much of what patients want to understand about Lyme disease can be learned by studying syphilis.
Whether one agrees with every conclusion MacDonald reached or not, the larger point is worth taking seriously. Syphilis is the older, better-documented spirochetal disease. It teaches medicine how a spirochete can move through stages, affect the skin, involve the nervous system, mimic other diseases, complicate testing, and cause devastating late consequences when missed.
That comparison should not be treated as heresy. Yet in some Lyme-focused spaces, raising syphilis as part of the differential can become a point of ostracism. Patients may be pressured to keep the discussion inside a Lyme-only narrative, even when the rash pattern, neurologic symptoms, testing limitations, or history justify asking whether syphilis has been ruled out.
That is not patient-centered care. Morgellons patients deserve the full differential, not a loyalty test.
What Morgellons Patients Should Ask Their Clinician
This article is not medical advice and does not diagnose anyone. But it can help patients prepare better questions. If a Morgellons-like or Lyme-like illness involves rash, lesions, neurologic symptoms, eye or ear symptoms, congenital concerns, or confusing test results, patients may want to ask:
- Was syphilis considered in the differential diagnosis?
- Were both treponemal and nontreponemal syphilis tests performed?
- If syphilis was previously treated, were RPR or VDRL titers followed appropriately?
- Could a positive Lyme screening test be a false positive related to another spirochetal infection?
- Could relapsing fever Borrelia be complicating the Lyme interpretation?
- Does the rash pattern fit secondary syphilis, Lyme disease, another infection, medication reaction, or something else?
- Were palms, soles, mucous membranes, eyes, ears, and neurologic symptoms evaluated?
- Is there any pregnancy, congenital, family, or childhood history that makes syphilis worth reconsidering?
- If PCR or tissue testing was negative, was the specimen type adequate for the question being asked?
Patients should not self-diagnose from the internet. But they should also not be silenced when the differential diagnosis has not been completed.
The Bottom Line on Morgellons, Lyme Disease, and Syphilis
Morgellons patients deserve to be believed, examined, and protected from oversimplified explanations. Lyme disease may matter for some patients. Tick-borne infections may matter for some patients. But syphilis is the spirochetal diagnosis patients should not ignore when the clinical picture makes it relevant.
Syphilis is resurging. It can be congenital. It can be infectious in ways families and clinicians may not expect. It can present with macular, papular, or maculopapular rashes. It can affect the nervous system and cardiovascular system. It can complicate Lyme testing. It can be difficult to confirm in late-stage or tissue-based scenarios. And negative PCR does not always end the question.
The patient-safety message is simple: do not let anyone stop the investigation at “Lyme explains it.” Morgellons patients deserve evidence, differential diagnosis, and honest uncertainty.
Frequently Asked Questions About Morgellons and Lyme Disease
Does Morgellons automatically mean Lyme disease?
No. Lyme disease may matter for some Morgellons patients, but Morgellons should not automatically be treated as Lyme disease without considering rash patterns, testing limitations, geography, relapsing fever Borrelia, syphilis, and other possible explanations.
Is Morgellons caused by syphilis?
This article does not claim that Morgellons is caused by syphilis. The point is that syphilis can mimic other illnesses, affect the skin and nervous system, complicate Lyme testing, and should be considered when the clinical picture fits.
Can syphilis cause a false-positive Lyme test?
Yes. CDC notes that false-positive Lyme serology can occur in patients with other conditions, including syphilis. That means a positive Lyme screen should be interpreted carefully, especially when the patient has rash, neurologic symptoms, or other features that could fit syphilis.
Can Lyme disease cause a false-positive syphilis screen?
Available evidence does not appear to support the reverse problem in the same way. A published study found evidence against previous Borrelia burgdorferi infection causing false-positive syphilis screening tests.
Are macular, papular, or maculopapular rashes important in Morgellons patients?
Yes. Morgellons staging literature has described macular and small papular skin findings, and patients may present with rashes that appear macular, papular, or maculopapular. Because these rash patterns can also occur in secondary syphilis, viral illness, drug reactions, and other conditions, they should prompt careful differential diagnosis.
Does Borrelia mayonii cause maculopapular rash?
The reported case discussed in this article described patchy or confluent macular erythema, not specifically maculopapular rash. This distinction matters because rash morphology should be described accurately before diagnostic conclusions are made.
Does a negative syphilis PCR rule out syphilis?
Not always. PCR depends on specimen type, disease stage, organism burden, tissue handling, and test design. A negative PCR from one specimen should not be treated as absolute proof when the broader clinical or histologic picture still raises concern.
Why mention Australia in an article about Morgellons and Lyme disease?
Australia is a useful comparison because locally acquired classic Lyme disease has not been convincingly established there, while syphilis is clearly resurging and has triggered a national public-health response. That contrast shows why a Lyme-only lens can miss other diagnoses.
Sources and Further Reading
- CDC: Clinical Testing and Diagnosis for Lyme Disease
- Lyme disease does not cause false-positive syphilis screens
- CDC: Sexually Transmitted Infections Surveillance
- CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
- CDC: Syphilis STI Treatment Guidelines
- CDC: Hard Tick Relapsing Fever Guidance
- South Carolina DPH: STI Awareness Week and Congenital Syphilis Data
- Georgia Department of Public Health: STD Data and Statistics
- Australian CDC: Syphilis Declared a Communicable Disease Incident of National Significance
- Medical Journal of Australia: Does Lyme Disease Exist in Australia?
- Case report and review: Acquired syphilis in a child and close-contact transmission
- Acquired Syphilis in a Chinese Family Among Three Generations
- A ruptured thoracic aortic aneurysm and the difficulties of confirming syphilis
- CDC MMWR: Borrelia mayonii Lyme Disease — New York, 2025
- Borrelia mayonii case describing patchy macular erythema
- Classification and Staging of Morgellons Disease
- Morgellons Disease: A Filamentous Borrelial Dermatitis
Related Morgellons Resources
- What Is Morgellons Disease?
- Morgellons Research and Published Studies
- Find a Morgellons Doctor
- When It Might Not Be Morgellons
- Morgellons Disease Blog
This article is for educational and advocacy purposes only. It is not medical advice and does not diagnose or treat any condition. If you have a rash, skin lesions, neurologic symptoms, suspected tick-borne illness, possible syphilis exposure, pregnancy concerns, or worsening systemic symptoms, consider seeking evaluation from a qualified medical professional.
